NEW YORK (GenomeWeb) – Antibiotic resistance diagnostics firm MicrobeDx today announced it has received up to $3.5 million in funding from CARB-X.

The award will be used by Los Angeles-based MicrobeDx to develop its diagnostic technology, which uses a compact desktop device to detect the presence of bacteria in clinical urine specimens, and to which antibiotics they are susceptible. Bacteria can be detected within 30 minutes, while complete antimicrobial susceptibility detection can be completed within three hours with the system, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Sponsored by

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Sponsored by

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sponsored by

This webinar will discuss an approach for automating variant classification based on the American College of Medical Genetics and Genomics guidelines.

Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.